Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1646 (LINC01646) is a long intergenic non-coding RNA (lincRNA), defined by its transcription from a region of the genome that does not overlap with protein-coding genes[1][5][7]. LINC01646 is annotated in gene databases and belongs to the lincRNA subclass of long non-coding RNAs, which are typically longer than 200 nucleotides and generally do not encode proteins[3][7]. LincRNAs as a group play roles in modulation of gene expression, chromatin dynamics, and potentially act as transcriptional enhancers or regulators, but the specific biological function or disease relevance of LINC01646 remains uncharacterized in peer-reviewed literature and public databases as of this date[1][3][5].
Not documented. No mechanisms of drug action targeting LINC01646 were reported.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1646 (LINC01646).